Recombinant Vibrio fischeri Triosephosphate isomerase (tpiA)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder. We will preferentially ship the format we have in stock. If you have a specific format requirement, please note it when ordering, and we will fulfill your request.
Lead Time
Delivery times vary depending on the purchasing method and location. Please consult your local distributor for specific delivery information. All proteins are shipped with standard blue ice packs. If dry ice is required, please inform us in advance, as additional charges will apply.
Notes
Avoid repeated freezing and thawing. Working aliquots can be stored at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening to collect the contents at the bottom. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on several factors, including storage conditions, buffer components, storage temperature, and protein stability. Generally, the liquid form has a shelf life of 6 months at -20°C/-80°C, while the lyophilized form has a shelf life of 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type will be determined during the manufacturing process. If you require a specific tag type, please let us know, and we will prioritize developing it.
Synonyms
tpiA; VFMJ11_0197; Triosephosphate isomerase; TIM; TPI; EC 5.3.1.1; Triose-phosphate isomerase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-256
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Vibrio fischeri (strain MJ11)
Target Names
tpiA
Target Protein Sequence
MRHPVVMGNW KLNGSKEMVV ELLNGLNAEL EGVTGVDVAV APPALFVDLA ERTLTEAGSA IILGAQNTDL NNSGAFTGDM SPAMLKEFGA THIIIGHSER REYHNESDEF VAKKFAFLKE NGLTPVLCIG ESEAQNEAGE TVAVCARQID AVINTQGVDA LNGAIIAYEP IWAIGTGKAA TAEDAQRIHA QIRAHIAEKS EEVAKNVVIQ YGGSVKPENA AAYFAQPDID GALVGGAALD AKSFAAIAKA AAEAKA
Uniprot No.

Target Background

Function
Involved in gluconeogenesis. Catalyzes the stereospecific conversion of dihydroxyacetone phosphate (DHAP) to D-glyceraldehyde-3-phosphate (G3P).
Database Links
Protein Families
Triosephosphate isomerase family
Subcellular Location
Cytoplasm.

Q&A

What is the role of triosephosphate isomerase in Vibrio fischeri metabolism?

Triosephosphate isomerase (tpiA) in Vibrio fischeri, like other TIM enzymes, catalyzes the reversible interconversion between glyceraldehyde 3-phosphate and dihydroxyacetone phosphate. This reaction is essential for glycolysis and gluconeogenesis pathways . In the context of V. fischeri's symbiotic relationship with its host, the bobtail squid Euprymna scolopes, this enzyme likely plays a crucial role in energy metabolism during colonization and bioluminescence production. While V. fischeri-specific TIM has not been extensively characterized compared to other bacterial TIMs, its function in central carbon metabolism supports the energetic requirements for the bacterium's symbiotic lifestyle.

How does the structure of V. fischeri tpiA compare to other bacterial TIMs?

Based on structural studies of other triosephosphate isomerases, V. fischeri TIM likely maintains the canonical TIM barrel fold consisting of eight α-helices and eight parallel β-strands. While specific structural data for V. fischeri TIM is not widely available, comparative analysis with other bacterial TIMs suggests potential unique features. For instance, the unusually high cysteine content observed in tick embryo TIM (BmTIM, with nine cysteine residues per monomer) raises the question of whether V. fischeri TIM might also possess distinctive cysteine content or distribution that could affect its stability or regulation in the context of the marine symbiotic environment.

What expression systems are most effective for recombinant V. fischeri tpiA production?

For recombinant expression of V. fischeri tpiA, researchers can leverage several approaches:

  • Homologous Expression: Using modified genetic tools developed specifically for V. fischeri, such as the IPTG-inducible system described in the literature . This approach involves:

    • Inserting the lacI gene into the V. fischeri chromosome

    • Using a LacI-repressible promoter (such as A1/34) to control tpiA expression

    • Inducing expression with IPTG when desired

  • Heterologous Expression: Standard E. coli expression systems (BL21, Rosetta) can be employed with codon optimization if necessary, especially when large quantities of protein are required.

The advantage of homologous expression is the potential for proper folding in the native cellular environment, while heterologous expression typically yields higher protein amounts. For most structural and biochemical studies, the E. coli system may be sufficient, while studies focused on in vivo function might benefit from the homologous system.

What purification strategy yields the highest activity for recombinant V. fischeri tpiA?

A recommended purification protocol for V. fischeri tpiA would involve:

  • Affinity chromatography using His-tag or other fusion tags

  • Ion exchange chromatography to remove contaminants

  • Size exclusion chromatography for final purification and buffer exchange

Critical considerations include:

  • Maintaining reducing conditions throughout purification if the enzyme contains accessible cysteine residues, as observed in other TIMs

  • Temperature control during purification (4°C recommended)

  • Including glycerol (10-20%) in storage buffers to maintain stability

  • Verifying enzyme activity after each purification step using standard TIM activity assays

What are the expected kinetic parameters for V. fischeri tpiA and how do they compare to other TIMs?

While specific kinetic parameters for V. fischeri TIM aren't reported in the provided literature, we can refer to values from related systems. For comparison, the table below presents kinetic parameters of TIM from different sources:

SourceSubstrateKm (mM)Vmax (μmol·min⁻¹·mg⁻¹)Reference
R. microplus (tick) TIMGlyceraldehyde 3-phosphate0.476031
E. coli TIM (estimated)Glyceraldehyde 3-phosphate0.3-0.54000-5000Literature values
V. fischeri TIM (predicted)Glyceraldehyde 3-phosphate0.4-0.6*5000-7000*Extrapolated prediction

*These values are estimates based on evolutionary relationships and similar bacterial TIMs.

When characterizing V. fischeri TIM, researchers should measure activity under various pH conditions (likely optimal around pH 7.5-8.0) and temperature ranges (expected optimum 25-30°C, reflecting the natural marine environment of V. fischeri).

How might tpiA function be regulated in the context of V. fischeri's symbiotic lifestyle?

V. fischeri's symbiotic relationship with the squid Euprymna scolopes involves complex regulation of many processes. While specific regulation of tpiA is not detailed in the provided literature, several potential regulatory mechanisms can be hypothesized:

  • NO-mediated regulation: V. fischeri is exposed to host-derived nitric oxide (NO) during colonization . The H-NOX protein in V. fischeri acts as an NO sensor and regulates the expression of multiple genes. It's possible that glycolytic genes including tpiA might be indirectly regulated in response to NO, particularly since metabolism would need to adapt during the different stages of colonization.

  • Iron availability: H-NOX-mediated NO sensing has been shown to regulate iron metabolism in V. fischeri . Since many metabolic enzymes require metal cofactors, changes in iron availability might indirectly affect tpiA activity.

  • Quorum sensing: V. fischeri is known to utilize quorum sensing for bioluminescence regulation. This system might also influence central metabolism during colonization transitions.

How can the IPTG-inducible system be optimized for controlled expression of tpiA in V. fischeri?

The IPTG-inducible system in V. fischeri can be optimized for tpiA expression using the following approach:

  • Promoter selection: The LacI-repressible promoter A1/34 has been shown to function as a strong promoter in V. fischeri . This promoter contains two LacI binding sites - one between the -35 and -10 sites and another overlapping the transcriptional start site.

  • Vector construction: For controlled expression, use a mini-Tn5 transposon with the A1/34 promoter positioned to drive tpiA expression .

  • Host strain preparation: Insert the lacIq gene into the V. fischeri chromosome, preferably adjacent to the Tn7 site (between yeiR and the Tn7 site) to ensure proper regulation .

  • Induction optimization: Determine the optimal IPTG concentration for induction. Starting with a range of 0.1-1.0 mM is recommended, with time-course analysis to determine peak expression.

  • Verification: Confirm that the lacIq allele is functional by testing its ability to control gene expression from the lac promoter .

What approaches can be used to study the role of tpiA in V. fischeri colonization?

Several methodological approaches can be employed to investigate tpiA's role in colonization:

  • Conditional expression: Using the IPTG-inducible system described above to control tpiA expression during different stages of colonization .

  • Gene knockout and complementation: Generate a tpiA knockout mutant and complement with controlled expression constructs to assess colonization efficiency. This approach was successfully used to study PepN in V. fischeri colonization .

  • Competition assays: Compare colonization efficiency between wild-type and tpiA-modified strains in competition experiments, similar to those used for PepN studies . Calculate and monitor the relative competitive index (RCI) over time.

  • In vivo imaging: Use the natural bioluminescence of V. fischeri to track colonization patterns and density non-invasively.

  • Transcriptional profiling: Analyze changes in gene expression during colonization to identify co-regulated genes and pathways associated with tpiA.

How might tpiA contribute to the energetics of bioluminescence in V. fischeri?

Bioluminescence in V. fischeri requires significant energy resources, and as a central glycolytic enzyme, tpiA likely plays an important role in this process:

  • Metabolic flux contribution: TIM's role in connecting the two branches of glycolysis makes it a potential control point for directing carbon flux toward energy production versus biosynthetic pathways.

  • NADH production: The glycolytic pathway generates NADH, which is necessary for the reduction of FMN to FMNH₂, a substrate for the luciferase reaction. Efficient tpiA function ensures proper glycolytic flux and adequate NADH production.

  • Energy balance: During symbiotic colonization, V. fischeri must balance energy allocation between growth, maintenance, and bioluminescence. The activity and regulation of tpiA may influence this energy partitioning.

  • Adaptation to host environment: Similar to how V. fischeri adapts to host-derived NO through H-NOX sensing , the activity or expression of tpiA might be modulated in response to changing conditions within the light organ environment.

How can structural analyses of V. fischeri tpiA inform the development of specific inhibitors?

Structural analysis of V. fischeri tpiA could reveal unique features that might be exploited for the development of specific inhibitors:

  • Cysteine content analysis: The high cysteine content observed in some TIMs (e.g., BmTIM with nine cysteine residues per monomer ) can provide targets for species-specific inhibitors. Structural analysis would reveal whether V. fischeri TIM contains exposed cysteine residues that could be targeted.

  • Active site comparison: Detailed structural analysis of the active site architecture could identify subtle differences between V. fischeri TIM and related enzymes that might be exploited for selective inhibition.

  • Allosteric site identification: Beyond the active site, structural analysis could reveal unique allosteric sites that might be targeted for inhibition or activation.

  • Dimer interface targeting: Since TIMs typically function as dimers, analyzing the dimer interface might reveal opportunities for developing inhibitors that specifically disrupt V. fischeri TIM dimerization.

  • Dynamic analysis: Molecular dynamics simulations based on structural data could identify conformational changes unique to V. fischeri TIM that might be targeted.

What strategies can address poor solubility of recombinant V. fischeri tpiA?

If encountering solubility issues with recombinant V. fischeri tpiA, researchers can implement these methodological solutions:

  • Expression temperature modification: Lower the expression temperature to 16-20°C to slow protein folding and improve solubility.

  • Fusion tag selection: Test different fusion tags known to enhance solubility (SUMO, MBP, TrxA) in addition to standard His-tags.

  • Buffer optimization: Screen multiple buffer conditions varying in:

    • pH range (7.0-8.5)

    • Salt concentration (100-500 mM NaCl)

    • Addition of stabilizing agents (5-10% glycerol, 1-5 mM DTT or β-mercaptoethanol)

    • Presence of osmolytes (trehalose, sucrose)

  • Co-expression with chaperones: Co-express with molecular chaperones (GroEL/GroES, DnaK/DnaJ) to assist proper folding.

  • Refolding protocols: If inclusion bodies form, develop a refolding protocol involving gradual dilution or dialysis from denaturants.

How can researchers address inconsistent activity in purified V. fischeri tpiA preparations?

Inconsistent enzyme activity can be addressed through these approaches:

  • Metal contamination assessment: Test for inhibitory metal ions using EDTA treatment followed by activity recovery with specific metal addition.

  • Oxidation prevention: If the enzyme contains sensitive cysteine residues, maintain reducing conditions (1-5 mM DTT or TCEP) throughout purification and storage.

  • Storage condition optimization: Test enzyme stability in different storage conditions:

    • Buffer compositions

    • Protein concentrations (0.1-5 mg/ml)

    • Storage temperatures (-80°C, -20°C, 4°C)

    • Addition of stabilizers (glycerol, sucrose, BSA)

    • Flash-freezing vs. gradual cooling

  • Activity assay validation: Ensure the assay method properly accounts for:

    • pH optima

    • Temperature sensitivity

    • Substrate concentration effects

    • Presence of inhibitory contaminants

  • Batch consistency monitoring: Implement quality control measures including SDS-PAGE, activity assays, and thermostability tests for each preparation.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.